| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Galliford Try wins £750m affordable homes framework contract | ||
| Di | Raymond James raises Altius Minerals stock price target on revenue growth | ||
| Di | William Blair reiterates Eupraxia stock rating on trial data | ||
| Di | BofA raises PG&E stock price target to $23 on capital investment | ||
| Di | Blue Bird stock rating reiterated at Buy by Craig-Hallum on strong positioning | ||
| Di | Magnite stock rating maintained at Buy by Craig-Hallum amid exits | ||
| Di | BofA raises Synchrony Financial price target on volume trends | ||
| Di | Kemper completes sale of captive agent business to Confie | ||
| Di | Klarna resell feature sees 75% growth in listings over 13 months | ||
| Di | Prosus non-executive director Steve Pacak passes away | ||
| Di | Macquarie raises Rio Tinto stock price target on aluminum strength | ||
| Di | Telsey reiterates Tractor Supply stock rating after soft quarter | ||
| Di | Black Diamond to present silevertinib data at ASCO meeting | ||
| Di | Karyopharm's myelofibrosis trial selected for ASCO presentation | ||
| Di | Regeneron submits U.S. application for gMG treatment cemdisiran | ||
| Di | Immunome's desmoid tumor trial data selected for ASCO presentation | ||
| Di | RBC Capital reiterates Westlake Chemical stock rating on new CFO | ||
| Di | RBC Capital maintains Shopify stock rating on strong e-commerce data | ||
| Di | Mizuho raises GE Vernova stock price target on data center demand | ||
| Di | Jefferies raises FirstEnergy stock price target on regulatory outlook | ||
| Di | UBS reiterates Buy on Block stock, $90 target on design focus | ||
| Di | RBC Capital reiterates Exelixis stock rating on competitive position | ||
| Di | Immatics announces four oral presentations at ASCO meeting | ||
| Di | Ondo InsurTech reports 19% revenue growth, seeks funding | ||
| Di | Why is Intel stock climbing again today? |